Innovations-Magazine-Nov-Dec-2024 - 15

ASSOCIATION NEWS
The Task Force to Review Institutional Pharmacy and Compounding Model Rules met at NABP Headquarters on September 30-October 1, 2024.
2 Amend, if necessary, the Model
Act accordingly.
The chairperson of this task force was
Julie Spier, RPh, Texas State Board of
Pharmacy. Individuals appointed to serve
as members included the following:
* Diane Halvorson, RPhTech,
CSPT, CPhT-Adv, North Dakota
Board of Pharmacy
* William Hayes, PharmD, CCHP,
Washington State Pharmacy Quality
Assurance Commission
* Mark G. Klang, MS, PhD, RPh,
BCNSP, New York State Board of
Pharmacy
* Tyler Laetsch, PharmD, RPh, South
Dakota Board of Pharmacy
* Brenda McCrady, PD, Arkansas
State Board of Pharmacy
* Mark Mikhael, PharmD, RPh, Florida
* Karen M. Ryle, MS, RPh,
Massachusetts
* Ashley Schaber, MBA, PharmD,
RPh, BCPS, DPLA, Alaska Board of
Pharmacy
* Donna C. Yeatman, RPh, Alabama
State Board of Pharmacy
Michael Blaire, RPh, Arizona; Timothy
R. Koch, RPh, PD, CHC, Arkansas; Todd
Larimer, RP, Nebraska Board of Pharmacy;
Eileen Ortega, RPh, Puerto Rico Board
of Pharmacy; Mark Sciaraffa, CPhT,
Massachusetts Board of Registration in
Pharmacy; Lucy Shell, PharmD, DPh,
Tennessee Board of Pharmacy; and Terry
Talbott, RPh, Pennsylvania State Board of
Pharmacy, served as alternates. The Executive
Committee liaison was Stacey Ranucci,
MBA, RPh, BGCP, CDCES, FASCP.
The Steering Committee for the NABP
Research and Innovation Institute met at
NABP Headquarters on November 12-13,
2024. The committee was established in
response to Mesaros' presidential initiative.
The committee was charged with the
following objectives:
1 Review and discuss the goals of
Mesaros' presidential initiatives, which
establishes the new NABP Research and
Innovation Institute;
2 Recommend any additional goals
that should be considered through
the initiative;
3 Evaluate tentative pathways for
interested stakeholders to identify
innovative processes for boards of
pharmacy to consider to begin
accomplishing these goals;
4 Recommend additional potential
stakeholders and their possible roles in
the initiative; and
5 Review submitted proposals from
interested stakeholders and determine
commitments.
The chairperson of this committee was
Kimberly Grinston, JD, Missouri Board of
Pharmacy. Individuals appointed to serve as
members included the following:
* Ronda Marie Chakolis, MPH, PharmD,
Minnesota Board of Pharmacy
* John L. Colaizzi, Jr, PharmD, RPh,
CCP, FNJPhA, New Jersey State Board
of Pharmacy
* Cecil H. Cordle, PharmD, RPh, Georgia
Board of Pharmacy
* Reginald B. " Reggie " Dilliard,
DPh, Tennessee
* Allison L. Hill, PharmD, RPh,
District of Columbia Board
of Pharmacy
* Richard M. Indovina, Jr, MBA, RPh,
Louisiana Board of Pharmacy
* Richard A. " Rich " Palombo, RPh, DPh,
New Jersey
* Priyal Patel, RPh, Oregon Board
of Pharmacy
* Denise Scarpelli, MBA, PharmD,
RPh, Illinois Department of Financial
and Professional Regulation, Division of
Professional Regulation - State Board
of Pharmacy
* Christian Tadrus, PharmD, RPh, NSC-I,
Missouri Board of Pharmacy
* Beverley A. Zwicker, RPh, Nova Scotia
College of Pharmacists
Micah Cost, MS, PharmD, CAE,
Pharmacy Quality Alliance; Greg Myers,
MBA, Deloitte; Krystalyn Weaver, PharmD,
JD, National Alliance of State Pharmacy
Associations; and President Mesaros were
guests. The Executive Committee liaison was
Bradley S. Hamilton, BSPharm, RPh.
NOV/DEC 2024 | 13

Innovations-Magazine-Nov-Dec-2024

Table of Contents for the Digital Edition of Innovations-Magazine-Nov-Dec-2024